TrialCPT: pharmacometrics & systems pharmacology2022

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease.

Kumar Kandadi Muralidharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.